The CALD1 gene, the putative target of gga-miR-27b, encodes two caldesmon-1 isoforms through alternative splicing: high molecular mass CaD (h-CaD), which is exclusively expressed in smooth muscle, and low molecular mass CaD (l-CaD), which is ubiquitously expressed in all cell types except skeletal muscle.